Quick Answer
GRI Bio, Inc. reported Total Revenue of $0.00 for the year ending 2021.
- GRI Bio, Inc. showed a decrease of -100.0% in Total Revenue from 2020 to 2021.
- This data is from GRI Bio, Inc.'s annual report (Form 10-K), filed with the SEC on February 14, 2022.
- XBRL data for this metric is available from 2020 to 2021 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2020: $100.0 thousand | Q2 2020: $0.00 | Q3 2020: $0.00 | Q1 2021: $0.00 | Q2 2021: $0.00 | Q3 2021: $0.00 | Q1 2022: $0.00.
- Historical annual values: Fiscal year 2021: $0.00 | Fiscal year 2020: $100.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: